Charles River Laboratories Market Cap 2010-2023 | CRL
Charles River Laboratories market cap history and chart from 2010 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Charles River Laboratories market cap as of April 15, 2024 is $12.43B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.432B | $4.129B |
| Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $115.766B | 15.02 |
| Cencora (COR) | United States | $46.679B | 18.63 |
| ICON (ICLR) | Ireland | $25.244B | 24.90 |
| DiDi Global (DIDIY) | China | $23.367B | 0.00 |
| Avantor (AVTR) | United States | $16.930B | 23.33 |
| CochLear (CHEOY) | $13.697B | 0.00 | |
| Viatris (VTRS) | United States | $13.592B | 3.88 |
| Revvity (RVTY) | United States | $12.784B | 22.26 |
| Medpace Holdings (MEDP) | United States | $12.238B | 44.48 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.209B | 0.00 |
| Natera (NTRA) | United States | $11.408B | 0.00 |
| Solventum (SOLV) | $10.825B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.851B | 51.19 |
| Bausch + Lomb (BLCO) | Canada | $4.998B | 19.24 |
| Doximity (DOCS) | United States | $4.826B | 35.93 |
| Organon (OGN) | United States | $4.461B | 4.32 |
| Surgery Partners (SGRY) | United States | $3.334B | 30.98 |
| Progyny (PGNY) | United States | $3.300B | 55.16 |
| Sotera Health (SHC) | United States | $3.193B | 15.67 |
| Life Times (LTH) | United States | $2.817B | 31.13 |
| GoodRx Holdings (GDRX) | United States | $2.698B | 136.60 |
| Premier (PINC) | United States | $2.527B | 9.25 |
| Teladoc Health (TDOC) | United States | $2.406B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.146B | 6.94 |
| Agilon Health (AGL) | United States | $2.027B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.720B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.453B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.381B | 0.00 | |
| Agiliti (AGTI) | United States | $1.366B | 22.33 |
| Alignment Healthcare (ALHC) | United States | $0.888B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.776B | 8.03 |
| Embecta (EMBC) | United States | $0.590B | 3.90 |
| Auna S.A (AUNA) | Luxembourg | $0.569B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.536B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| Enhabit (EHAB) | United States | $0.522B | 47.27 |
| MultiPlan (MPLN) | United States | $0.507B | 0.00 |
| Beauty Health (SKIN) | United States | $0.452B | 0.00 |
| CareDx (CDNA) | United States | $0.442B | 0.00 |
| LifeMD (LFMD) | United States | $0.390B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.340B | 54.33 |
| ModivCare (MODV) | United States | $0.319B | 4.23 |
| Sera Prognostics (SERA) | United States | $0.313B | 0.00 |
| Sharecare (SHCR) | United States | $0.266B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.252B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.251B | 0.00 |
| Biodesix (BDSX) | United States | $0.119B | 0.00 |
| So-Young (SY) | China | $0.116B | 39.00 |
| Oncology Institute (TOI) | United States | $0.095B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.040B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Medical (BIMI) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |